Right to Documentation. Upon request, REVIMMUNE shall have the right to request reasonable documentation of ACCENTIA’s sublicensed royalty calculations to confirm the accuracy thereof and to request discussion of such calculations with appropriate representatives of ACCENTIA.
Appears in 2 contracts
Sources: Sublicense Agreement, Sublicense Agreement (Accentia Biopharmaceuticals Inc)